The effect of coimmobilizing heparin and fibronectin on titanium on hemocompatibility and endothelialization

Biomaterials

Volumn 32, Issue 21, 2011, Pages 4691-4703

  Li, Guicai ^a   Yang, Ping ^a   Qin, Wei ^a   Maitz, Manfred F ^a,b   Zhou, Shuo ^a   Huang, Nan ^a  

^a SOUTHWEST JIAOTONG UNIVERSITY   (China)

^b LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

Author keywords

Blood compatibility; Coimmobilization; Endothelialization; Fibronectin; Heparin; Stability

Indexed keywords

BLOOD COMPATIBILITY; COIMMOBILIZATION; ENDOTHELIALIZATION; FIBRONECTIN; HEPARIN;

BINDING SITES; BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BLOOD; COAGULATION; ENDOTHELIAL CELLS; IMPLANTS (SURGICAL); TITANIUM;

POLYSACCHARIDES;

BIOMATERIAL; FIBRINOGEN; FIBRONECTIN; HEPARIN; TITANIUM;

ARTICLE; BINDING SITE; BIOCOMPATIBILITY; BLOOD CLOTTING TIME; CELL PROLIFERATION; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DENSITY; ENDOTHELIUM CELL; HEART VALVE PROSTHESIS; HEMOLYSIS; HUMAN; HUMAN CELL; IMPLANT; PRIORITY JOURNAL; STENT; TECHNIQUE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; WETTABILITY;

ANIMALS; ANTITHROMBIN III; CELL PROLIFERATION; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; ENDOTHELIAL CELLS; FIBRONECTINS; HEPARIN; HUMANS; MATERIALS TESTING; MICROSCOPY, ATOMIC FORCE; PHOTOELECTRON SPECTROSCOPY; PLATELET ACTIVATION; PLATELET ADHESIVENESS; SINCALIDE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TITANIUM;

EID: 79955767302     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.03.025     Document Type: Article

References (50)

1. Ratner B.D. New ideas in biomaterials science-a path to engineered biomaterials. J Biomed Mater Res 1993, 27:837-850.
2. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29:2941-2953.
3. Balasubramanian V., Hall C.L., Shivashankar S., Slack S.M., Turitto V.T. Vascular cell attachment and procoagulant activity on metal alloys. J Biomater Sci Polym Edn 1998, 9:1349-1359.
4. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., Rickenbacher P., Hunziker P., Mueller C., et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006, 48:2584-2591.
5. Plant S.D., Grant D.M., Leach L. Behaviour of human endothelial cells on surfacemodified NiTi alloy. Biomaterials 2005, 26:5359-5367.
6. Huang N., Yang P., Leng Y.X., Chen J.Y., Sun H., Wang J., et al. Hemocompatibility of titanium oxide films. Biomaterials 2003, 24:2177-2187.
7. Weber N., Wendel H.P., Ziemer G. Hemocompatibility of heparin-coated surfaces and the role of selective plasma protein adsorption. Biomaterials 2002, 23:429-439.
8. Gong F.R., Cheng X.Y., Wang S.F., Zhao Y.C., Gao Y., Cai H.B. Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents. Acta Biomaterialia 2010, 6:534-546.
9. Zhu A.P., Zhang M., Wu J., Shen J. Covalent immobilization of chitosan/heparin mixture with a photosensitive hetero-bifunctional crosslinking reagent on PLA surface. Biomaterials 2002, 23:4657-4665.
10. Yin Y.B., Wise S.G., Nosworthy N.J., Waterhouse A., Bax D.V., Youssef H., et al. Covalent immobilisation of tropoelastin on a plasma deposited interface for enhancement of endothelialisation on metal surfaces. Biomaterials 2009, 30:1675-1681.
11. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24:4385-4415.
12. Guarnieri D., De Capu A., Ventre M., Borzacchiello A., Pedone C., Marasco D., et al. Covalently immobilized RGD gradient on PEG hydrogel scaffold influences cell migration parameters. Acta Biomaterialia 2010, 6:2532-2539.
13. Yang Z.L., Wang J., Luo R.F., Maitz M.F., Jing F.J., Sun H., et al. The covalent immobilization of heparin to pulsed-plasma polymeric allylamine films on 316L stainless steel and the resulting effects on hemocompatibility. Biomaterials 2010, 31:2072-2083.
14. Nojiri C., Noishiki Y., Koyanagi H. Aorta-coronary bypass grafting with heparinised vascular grafts in dogs. J Thorac Cardiovasc Surg 1987, 93:867-877.
15. Wang X.Y., Zhang X.H., Castellot J., Herman I., Iafrati M., Kaplan D.L. Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses. Biomaterials 2008, 29:894-903.
16. Meng S., Liu Z.J., Shen L., Guo Z., Chou L.L., Zhong W., et al. The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials 2009, 30:2276-2287.
17. Wang X.H., Li D.P., Wang W.J., Feng Q.L., Cui F.Z., Xu Y.X., et al. Covalent immobilization of chitosan and heparin on PLGA surface. Int J Biol Macromol 2003, 33:95-100.
18. Uygun B.E., Stojsih S.E., Matthew H.W.T. Effects of immobilized glycosaminoglycans on the proliferation and differentiation of mesenchymal stem cells. Tissue Eng Part A 2009, 15:3499-3512.
19. Adil D. Heparin-immobolized poly(2-hydroxyethylmethacrylate)-based microspheres. J Appl Sci 1999, 74:655-662.
20. Damus P.S., Hicks M., Rosenberg R.B. Anticoagulant action of heparin. Nature 1997, 246:355-357.
21. Middleton C.A., Pendegrass C.J., Gordon D., Jacob J., Blunn G.W. Fibronectin silanized titanium alloy: a bioinductive and durable coating to enhace fibroblast attachment in vitro. J Biomed Mater Res A 2007, 83:1032-1038.
22. Cho J.Y., Mosher D.F. Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi. Blood 2006, 107:3555-3563.
23. Richert L., Lavalle P., Payan E., Shu X.Z., Prestwich G.D., Stoltz J.F., et al. Layer by layer buildup of polysaccharide films: physical chemistry and cellular adhesion aspects. Langmuir 2004, 20:448-458.
24. Suri C.R., Mishra G.C. Activating piezoelectric crystal surface by silanization for microgravimetric immunobiosensor application. Biosens Bioelectron 1996, 11:1199-1205.
25. Shibuichi S., Onda T., Satoh N., Tsujii K. Super water- and oil-repellent surfaces resulting from fractal structure. J Phys Chem 1996, 100:19512-19517.
26. Alferiev I.S., Connolly J.M., Stachelek S.J., Ottey A., Rauova L., Levy R.J. Surface heparinization of polyurethane via bromoalkylation of hard segment nitrogens. Biomacromolecules 2006, 7:317-322.
27. Michanetzis G.P., Katsala N., Missirlis Y.F. Comparison of haemocompatibility improvement of four polymeric biomaterials by two heparinization techniques. Biomaterials 2003, 24:677-688.
28. Chuang T.W., Masters K.S. Regulation of polyurethane hemocompatibility and endothelialization by tethered hyaluronic acid oligosaccharides. Biomaterials 2009, 30:5341-5351.
29. Vana E.L., Grondahl L., Chuad K.N., Leongd K.W., Nurcombe V., Cool S.M. Controlled release of heparin from poly(e{open}-caprolactone)electrospun fibers. Biomaterials 2006, 27:2042-2050.
30. Li L.H., Tu M., Mou S.S., Zhou C.R. Preparation and blood compatibility of polysiloxane/liquid-crystal composite membranes. Biomaterials 2001, 22:2595-2599.
31. Kloczewiak M., Timmons S., Lukas T.J., Hawiger J. Platelet receptor recognition site on human-fibrinogen - synthesis and structurefunction relationship of peptides corresponding to the carboxyterminal segment of the gamma-chain. Biochem J 1984, 23:1767-1774.
32. Muller R., Abke J., Schnell E., Macionczyk F., Gbureck U., Mehrl R., et al. Surface engineering of stainless steel materials by covalent collagen immobilization to improve implant biocompatibility. Biomaterials 2005, 26:6962-6972.
33. VandeVondele S., Voros J., Hubbell J.A. RGD-grafted poly-l-lysine-graft- (polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. Biotechnol Bioeng 2003, 82:784-790.
34. Decher G. Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 1997, 277:1232-1237.
35. Bertrand P., Jonas A., Laschewsky A., Legras R. Ultrathin polymer coatings by complexation of polyelectrolytes at interfaces: suitable materials, structure and properties. Macromol Rapid Commun 2000, 21:319-348.
36. Lvov Y., Möhwald H. Protein architecture: interfacing molecular assemblies and immobilization technology 2000, Dekker, New York, 125-67.
37. Wissink M.J.B., Beernink R., Pieper J.S., Poot A.A., Engbers G.H.M., Beugeling T., et al. Immobilization of heparin to EDC/NHS-crosslinked collagen. characterization and in vitro evaluation. Biomaterials 2001, 22:151-163.
38. Puelo D.A. Activity of enzyme immobilized on silanized Co-Cr-Mo. J Biomed Mater Res 1995, 29:951-957.
39. Bunker B.C., Rieke P.C., Tarasevich B.J., Campbell A.A., Fryxell G.E., Graff G.L. Ceramic thin-film formation on functionalized interfaces through biomimetic processing. Science 1994, 264:48-55.
40. Nanci A., Wuest J.D., Peru L., Brunet P., Sharma V., Zalzal S., et al. Chemical modification of titanium surfaces for covalent attachment of biological molecules. J Biomed Mater Res 1998, 40:324-335.
41. Mrksich M., Whitesides G.M. Using self-assembled monolayers to understand the interactions of man-made surfaces with proteins and cells. Annu Rev Biophys Biomol Struct 1996, 25:55-78.
42. Mrksich M. Using self-assembled monolayers to model the extracellular matrix. Acta Biomaterialia 2009, 5:832-841.
43. Dinarvand R., Mahmoodi S., Farboud E., Salehi M., Atyabi F. Preparation of gelatin microspheres containing lactic acid-effect of crosslinking on drug release. Acta Pharmaceutica 2005, 55:57-67.
44. Luong-Van E., Groudahl T., Chua K.N., Leong K.W., Nurcombe V., Cool S.M. Controlled release of heparin from poly(e-caprolactone) electrospun fibers. Biomaterials 2006, 27:2042-2050.
45. Clowes A.W., Clowes M.M. Kinetics of cellular proliferation after arterial injury 2. inhibition of smooth-muscle growth by heparin. Lab Invest 1985, 52:611-616.
46. Renner L., Jorgensen B., Markowski M., Salchert K., Werner C., Pompe T. Control of fibronectin displacement on polymer substrates to influence endothelial cell behaviour. J Mater Sci Mater Med 2004, 15:387-390.
47. Capila I., Linhardt R.J. Heparin-protein interactions. Angew Chem Int Ed Engl 2002, 41:391-412.
48. Xu L.P., Pan F., Yu G.N., Yang L., Zhang E.L., Yang K. In vitro and in vivo evaluation of the surface bioactivity of a calcium phosphate coated magnesium alloy. Biomaterials 2009, 30:1512-1523.
49. Sousa J.E., Serruys P.W., Costa M.A. New frontiers in cardiology, drug-eluting stents: part l. Circulation 2003, 107:2274-2279.
50. Laemmel E., Penhoat J., Clerout R.W., Luizard M.F.S. Heparin immobilized on proteins usable for arterial prosthesis coating: growth inhibition of smooth-muscle cells. J Biomed Mater Res 1998, 39:446-452.